Search research articles
Contact Us
Filters
Showing results (481-490 of 611) with videos related to
Page
of 62
Sort By:
Neurology
|
February 1, 1981
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration
G Tell, P Böhlen, P J Schechter, et al.
Journal of Neurochemistry
|
February 1, 1989
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
D T Dexter, C J Carter, F R Wells, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 29, 2000
Irregular jerky tremor, myoclonus, and thalamus: a study using low-frequency stimulation
B P Bejjani, I Arnulf, M Vidailhet, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 27, 2001
Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis
A Hartmann, J D Troadec, S Hunot, et al.
Brain : a Journal of Neurology
|
June 1, 1993
Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone
J Blin, J C Baron, B Dubois, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1992
In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy
H Chabriat, M Levasseur, M Vidailhet, et al.
Neuroscience Letters
|
July 13, 2000
Age-related changes of neuronal counts in the human pedunculopontine nucleus
G Ransmayr, B Faucheux, C Nowakowski, et al.
Neurology
|
September 26, 2001
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions
S Lehéricy, S Grand, P Pollak, et al.
Nature Genetics
|
May 1, 1995
Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form
Y Trottier, D Devys, G Imbert, et al.
Advances in Neurology
|
January 1, 1993
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Y Agid, M Ruberg, F Javoy-Agid, et al.
Page
of 62
Search research articles
Search
Showing results (481-490 of 611) with videos related to
Sort By:
Page
of 62
Neurology
|
February 1, 1981
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration
G Tell, P Böhlen, P J Schechter, et al.
Journal of Neurochemistry
|
February 1, 1989
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
D T Dexter, C J Carter, F R Wells, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 29, 2000
Irregular jerky tremor, myoclonus, and thalamus: a study using low-frequency stimulation
B P Bejjani, I Arnulf, M Vidailhet, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 27, 2001
Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis
A Hartmann, J D Troadec, S Hunot, et al.
Brain : a Journal of Neurology
|
June 1, 1993
Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone
J Blin, J C Baron, B Dubois, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1992
In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy
H Chabriat, M Levasseur, M Vidailhet, et al.
Neuroscience Letters
|
July 13, 2000
Age-related changes of neuronal counts in the human pedunculopontine nucleus
G Ransmayr, B Faucheux, C Nowakowski, et al.
Neurology
|
September 26, 2001
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions
S Lehéricy, S Grand, P Pollak, et al.
Nature Genetics
|
May 1, 1995
Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form
Y Trottier, D Devys, G Imbert, et al.
Advances in Neurology
|
January 1, 1993
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Y Agid, M Ruberg, F Javoy-Agid, et al.
Page
of 62